Semnur Pharmaceuticals Inc (SMNR)
Health CareSnapshot 2026-11-04
$0.50-9.02%
Close 2026-09-04 · 1-day change
Health CareSnapshot 2026-11-04
QuarterlyIQ Insights · SMNR
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Model as of — · Company calendar date is not available
SMNR — litigation filed
Dated 2026-07-07
Entry into a Material Definitive Agreement. On July 3, 2026, Semnur Pharmaceuticals, Inc. (“the Company”) and iHolding Group LLP, a private investment group headquartered in Almaty, Republic of Kazakhstan (“iHolding”), entered into a binding term sheet (the “Term Sheet”). The Term Sheet contemplates that iHolding will purchase $100,000,000 (the “Proposed Investment”) of newly issued shares of Company common stock, par value $0.0001 per share (the “Company Common Stock”). The purchase price fo…
Why it matters: The investment may fund a company that still reports losses. A signed term sheet is not proof that the cash has arrived.
Supportive ifA company filing or release confirms the $100 million investment closed. It also confirms the company received the funds.
Worry ifThe term sheet ends, drops to a lower amount, or remains open in the next company update.
Why it matters: The latest reported net loss was $4.35 million, far below the $152.59 million loss in 2025-Q3. A sharp rise would break that improvement.
Worry ifA later quarter reports a net loss greater than $4.35 million. Exclude any one-time items if the filing gives those details.
Less concerning ifNet loss stays at or below $4.35 million in the next reported quarter.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$667 on $10,000 · ±6.7% | How much price usually moves either way. |
| Bad day | $3,568 loss on $10,000 · 35.7% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,848 loss on $10,000 · 98.5% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.